Respiratory Disorders Resource Center

Click on the subcategory below to find drug monographs for that particular area.

CPAP for Daytime Sleepiness in Seniors

CPAP is an effective treatment for daytime sleepiness in seniors with sleep apnea.

Children With Cystic Fibrosis, Longevity

In the U.S., children born in 2010 with cystic fibrosis are projected to live longer than those born earlier.

Vitamin D, Asthma Exacerbations

A new study has found a strong association between vitamin D levels and asthma exacerbations.

Secondhand Smoke, Allergic Disorders

The elevated risks with secondhand exposure in utero or in infancy for asthma and rhinitis were mainly found in early childhood, found a new study.

Asthma in Older Women

Older women face increased challenges in managing their asthma, including a higher asthma mortality rate.

Lung Cancer Risk, Respiratory Diseases

Several common respiratory diseases are tied to an increased risk of lung cancer.

Asthma Treatments: Inhalations

Review this updated chart on inhalations for asthma treatment for quick information when you need it.

New Drug Product: Breo Ellipta

Long term maintenance treatment of airflow obstruction in COPD, including chronic bronchitis and/or emphysema.

News

Sleep Apnea Tx May Cut Cardiovascular Surgical Complication Risk in Half

Screening and treating patients for obstructive sleep apnea before they have surgery may reduce their risk of cardiovascular complications by more than half.

Lead Poisoning Risk in Children's Powdered Product

The Food and Drug Administration (FDA) is warning parents and caregivers not to use "Bo Ying compound" manufactured by Eu Yan Sang (Hong Kong) Ltd. due a potential lead poisoning risk associated with the product.

FDA: Asthma Drug May Increase Risk of CV, Cerebrovascular Events

The Food and Drug Administration (FDA) is warning about a slightly increased risk of cardiovascular and cerebrovascular events among patients being treated with Xolair (omalizumab; Genentech and Novartis) for asthma compared to those not treated with Xolair.

Spiriva Respimat Approved for COPD Maintenance

Boehringer Ingelheim announced that the Food and Drug Administration (FDA) has approved Spiriva Respimat (tiotropium bromide) inhalation spray for the long-term, once-daily maintenance treatment of bronchospasm associated with chronic obstructive pulmonary disease (COPD).

Featured courses from mycme

Asthma and COPD: Providing Optimal Management (Pharmacology Credit)External web site

This program defines and distinguishes asthma from COPD, discusses the impact of these conditions on ...

CE 1.50 Credits

Red flags - Respiratory tract infectionsExternal web site

Red flags - Respiratory tract infections

0.50 Credits

Sign Up for Free e-newsletters